Register entry

Cambrex Karlskoga AB

Registered sites
1
Drug products
13
Live patents
0
Countries
1
Base
Sweden
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Cambrex Karlskoga ABKarlskogaSwedenAnalytical testing, Active ingredient (API) manufacture3001686607
Catalogue

Marketed products

13

Showing 13 of 13.

BrandGeneric nameFormCategory
-4-Amiinobenzoic acidPOWDERBULK INGREDIENT
-BUPIVACAINE HYDROCHLORIDEPOWDERBULK INGREDIENT
-Benzoyl peroxide, hydrousPOWDERBULK INGREDIENT
-Berotralstat DihydrochloridePOWDERBULK INGREDIENT
-Bupivacaine basePOWDERBULK INGREDIENT
-LIDOCAINEPOWDERBULK INGREDIENT
-Lidocaine hydrochloridePOWDERBULK INGREDIENT
-MesalaminePOWDERBULK INGREDIENT
-Momelotinib dihydrochloride monohydratePOWDERBULK INGREDIENT
-OlanzapinePOWDERBULK INGREDIENT
-RIVASTIGMINEPOWDERBULK INGREDIENT
-Tesofensine/NS2330 citratePOWDERBULK INGREDIENT
-ZongertinibPOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.